Best Options Strategy for RVMD
Looking for the best options strategy for Revolution Medicines, Inc. (RVMD)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RVMD option chain right now, and a simple map from your view on RVMD to the strategy that fits it. Model any of them in the calculator before you trade.
About RVMD
Revolution Medicines, Inc. (RVMD) is a major company in Biotechnology. Options traders on RVMD tend to watch , since these can drive large moves in the share price.
About Revolution Medicines, Inc.
Revolution Medicines is a clinical-stage biopharmaceutical company focused on oncology treatments targeting RAS-driven cancers. The company develops two main categories of drugs: RAS inhibitors that directly bind to mutated RAS proteins, designed to work either alone or paired with other therapies, and companion inhibitors that address secondary pathways that help sustain these cancers. Its lead candidate, daraxonrasib, is currently in a phase 3 trial combined with zoldonrasib for pancreatic cancer patients. The pipeline also includes elironrasib for solid tumors in early testing, along with several development-stage compounds targeting different RAS mutations including G12V, Q61H, and G13C variants.
The company generates no meaningful revenue at this stage, as it remains entirely focused on drug development rather than commercialization. Its business model centers on advancing its pipeline candidates through clinical trials toward regulatory approval, with the potential to eventually license or commercialize approved therapies. Founded in 2014 and based in Redwood City, California, Revolution Medicines operates in the competitive oncology drug development space where success…
Today's top-scoring strategy for RVMD
Our engine ranks defined-risk strategies on the live RVMD chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $160 | $1.15 |
| Sell | 1× | PUT | $175 | $3.60 |
| Sell | 1× | CALL | $195 | $4.60 |
| Buy | 1× | CALL | $210 | $1.75 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Live scan from 2026-07-02 · quotes delayed ~15 minutes
Implied volatility
RVMD is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 56% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on RVMD currently price in about 56% implied volatility, versus roughly 46% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$20.48 (±11%) in RVMD by 2026-07-17 — a range of roughly $164 to $205. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on RVMD carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
Liquidity and tradeability
RVMD options are thinly traded, with wide bid-ask spreads around 24.3% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
RVMD's next earnings report is due around August 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $40.2B
- Beta (vs market)
- 1.41
- 52-week range
- $34.00–$193.09 (95% up the range)
- Short interest
- 6.1% of float · 4.3 days to cover
How to choose an options strategy for RVMD
Start with your outlook on RVMD, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while RVMD stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open RVMD in the free calculator →
Frequently asked questions
What is the best options strategy for RVMD?
It depends on your outlook. Bullish traders often use a long call or bull call spread on RVMD; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are RVMD options liquid enough to trade?
Revolution Medicines, Inc. (RVMD) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade RVMD options?
Buying a single RVMD call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RVMD or any security. Do your own research.
What does Revolution Medicines, Inc. do?
Revolution Medicines, Inc. (RVMD) operates in the Biotechnology industry. The "About Revolution Medicines, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Revolution Medicines, Inc. pay a dividend?
Revolution Medicines, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
When does Revolution Medicines, Inc. next report earnings?
Revolution Medicines, Inc.'s next earnings are expected around August 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to RVMD
Comparing RVMD with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 700 Saginaw Drive, Redwood City, CA, 94063, United States
- Industry
- Biotechnology
- Employees
- 883
- CEO
- Dr. Mark A. Goldsmith M.D., Ph.D.
- Phone
- 650 481 6801
- Website
- www.revmed.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.